Antitumor Activity and Pharmacokinetics of TAS-106, 1-(3-C-Ethyny1-β-D-ribo-pentofuranosyl)cytosine

Search this Article

Author(s)

    • SHIMAMOTO Yuji
    • The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
    • FUJIOKA Akio
    • The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
    • KAZUNO Hiromi
    • The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
    • MURAKAMI Yuko
    • The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
    • KATO Toshiyuki
    • The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
    • MATSUDA Akira
    • Graduate School of Pharmaceutical Sciences, Hokkaido University

Journal

  • Jpn J Cancer Res

    Jpn J Cancer Res 92(3), 343-351, 2001-03-31

References:  22

Cited by:  3

Codes

  • NII Article ID (NAID)
    10008061514
  • NII NACSIS-CAT ID (NCID)
    AA00690844
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    09105050
  • Data Source
    CJP  CJPref 
Page Top